John Johnson

Director, Xeris Biopharma Holdings, Inc.; Director, Axogen, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.9M

Companies

Latest trade

Jun 4, 2026

Companies

Xeris Biopharma Holdings, Inc.Director −$1.1M Axogen, Inc.Director −$1.9M

Trades

XERS Sold 15,000 shares at $6.09 · planned $0.1M Jun 4

AXGN Sold 11,050 shares at $43.26 $0.5M May 7

XERS Sold 135,400 shares at $7.22 $1.0M Dec 19

AXGN Sold 21,686 shares at $29.98 $0.7M Dec 9

AXGN Sold 23,693 shares at $31.24 $0.7M Dec 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.